Fish display robust neuroendocrine and physiologic stress responses to noxious stimuli. Many anesthetic, sedative, or analgesic drugs used in other vertebrates reduce stress in fi sh, decrease handling trauma, minimize movement and physiologic changes in response to nociceptive stimuli, and can be used for euthanasia. But extrapolating from limited published anesthetic and sedative data to all fi sh species is potentially harmful because of marked anatomic, physiologic, and behavioral variations; instead, a stepwise approach to anesthetizing or sedating unfamiliar species or using unproven drugs for familiar species is advisable. Additionally, knowledge of how water quality infl uences anesthesia or sedation helps limit complications. The most common method of drug administration is through immersion, a technique analogous to gaseous inhalant anesthesia in terrestrial animals, but the use of injectable anesthetic and sedative agents (primarily intramuscularly, but also intravenously) is increasing. Regardless of the route of administration, routine preprocedural preparation is appropriate, to stage both the animals and the supplies for induction, maintenance, and recovery. Anesthetic and sedation monitoring and resuscitation are similar to those for other vertebrates. Euthanasia is most commonly performed using an overdose of an immersion drug but injectable agents are also effective. Analgesia is an area in need of signifi cant research as only a few studies exist and they provide some contrasting results. However, fi sh have µ and κ opiate receptors throughout the brain, making it reasonable to expect some effect of at least opioid treatments in fi sh experiencing noxious stimuli. Many anesthetic or analgesic drugs used in other vertebrates have been used in fi sh. In this review we focus on the practical considerations for these uses.
Introduction

W
hether or not fi sh feel pain is an ongoing debate. Although both sides of the argument set the same requirements for pain perception, opinions differ on where the criteria appear phylogenetically and whether or not parallel systems have evolved in different classes and species (Chandroo et al. 2004; Huntingford et al. 2006; Rose 2002; Sneddon 2003; Sneddon et al. 2003; Volpato 2009) . Each publication builds on or refutes earlier works, and a chronological evaluation of the literature is recommended (Neiffer 2007) .
Many anesthetic or analgesic drugs used in other vertebrates have been used in fi sh. In this review we focus on the practical considerations for these uses. Myszkowski et al. 2003; Ross and Ross 1984; Small 2003 Small , 2005 . Chemical restraint minimizes handling stress, but it is stressful (Bressler and Ron 2004) and is a strong potentiator of catecholamine release (Rothwell et al. 2005) . Although unbuffered immersion drugs induce a stress response (Ross and Ross 1984) , anesthesia-associated catecholamine release is likely due to hypoxemia rather than direct drug effects or acidemia (Ross and Ross 1984; Rothwell et al. 2005) . Hypoxemia in fi sh is usually due to drug-induced hypoventilation (decreased buccal movement). In anesthetized air-breathing fi sh, it can be exacerbated by preventing access to the water's surface (Rantin et al. 1993 (Rantin et al. , 1998 . Hypoventilation, and the resulting decreased water fl ow in the buccal cavity, usually leads to refl ex bradycardia and dorsal aortic hypotension, producing a progressive hypoxemia (Ross 2001) . Notwithstanding these negative effects, chemical sedation or anesthesia produces a lower stress response than drug-free handling and transport, based on a comparison of circulating cortisol levels as well as secondary indicators such as blood glucose, hematocrit (HCT), hemoglobin (Hgb), lactate, and osmolarity (Bressler and Ron 2004; Crosby et al. 2006; Hseu et al. 1996; Small 2005) .
Some researchers have argued that the stress-induced corticosteroid response is not harmful and is in fact essential for recovery from severe acute or prolonged stressors, and that a transient, relatively small elevation of cortisol does not necessarily reduce immunocompetency but may instead bolster it (Bressler and Ron 2004; Davis and Griffi n 2004; Small 2003; Thomas and Robertson 1991) . Based on this argument, drugs that suppress the HPI (e.g., metomidate, the only commonly used drug that consistently and signifi cantly blocks HPI activation in a broad range of species) are contraindicated in fi sh (Davis and Griffi n 2004; Iversen et al. 2003; Olsen et al. 1995; Small 2003; Thomas and Robertson 1991) . However, the contrary argument is that typical husbandry and handling procedures do not result in high stress levels associated with chronic immunosuppression (Bressler and Ron 2004; Davis and Griffi n 2004; Small 2003; Thomas and Robertson 1991) . For anesthetics that do not block the HPI, the intensity and duration of the stress response depend on either the duration of exposure or the drug, dosage, and species (Bressler and Ron 2004; Gomes et al. 2001; Thomas and Robertson 1991) .
In addition to affecting the stress response in some fi sh species, certain anesthetic/sedative drugs result in immunosuppression, either through direct interaction with immune components or indirectly through the nervous system (Bressler and Ron 2004) . For example, benzocaine signifi cantly depresses both humoral and cellular immune responses in gilthead seabream (Bressler and Ron 2004) . Metomidate, through its associated blockade of the HPI, is thought to prevent immunosuppression (Davis and Griffi n 2004) .
Considerations of Fish Taxonomy, Anatomy, and Physiology
Of the nearly 30,000 species of fi sh, 1 teleosts constitute approximately 96%, so most anesthesia studies involve these and, to a lesser extent, elasmobranchs (sharks, rays, and skates) and other fi sh. But given the anatomic, physiologic, and behavioral variation among fi sh, extrapolation of the limited published data to all species is potentially harmful. Development of anesthetic regimens for unfamiliar species-drug combinations will benefi t from an understanding both of fi sh natural history and of the taxonomic relationship between the species of concern and more studied species.
Respiration
Species-Related Respiratory Methods
All fi sh have gills, although reliance on these structures for respiration varies by species. Most force water over the gills through rhythmic movements of the lower jaw and opercula, but some use ram ventilation with minimal opercular movement. Among this latter group, some (e.g., tuna) are obligate ram ventilators-species that meet their respiratory demand by ensuring an adequate fl ow of water across the gills through constant forward motion with minimal or no opercular movement. For these species, failure to perfuse the gills during anesthesia causes suffocation (Brill and Bushnell 2001; Bushnell and Jones 1994) . 2 In response to hypoxic environments or other selective pressures, many species have evolved anatomical, physiologic, and behavioral adaptations for breathing (Graham 1997) . Such adaptations include modifi cations of gill design for improved oxygen extraction as well as the evolution of accessory respiratory organs, which for some species enable the use of atmospheric air. In many species, increased aerial gas exchange surface exists in portions of the anterior alimentary canal (i.e., the buccal and pharyngeal cavities) either as a direct proliferation of the respiratory surface in the lumen or as a single pouch or pair of pouches extending from it (Ishimatsu and Itazawa 1993) . Alternatively, branchial diverticulae exist, as in anabantoids (e.g., gouramis, bettas) (Graham 1997) .
Many species take in atmospheric air through aquatic surface respiration (ASR), positioning their mouths to skim the air/water interface, which is richer in oxygen. Some species (e.g., pacu, Piaractus mesopotamicus) respond to hypoxic conditions by developing temporary dermal swellings of the lower jaw to facilitate ASR (Rantin et al. 1993 (Rantin et al. , 1998 . Others (e.g., snakeheads, anabantoids) employ alternate fi lling of an air-breathing chamber (labyrinth organ in anabantoids) with air and water during aerial ventilation (Ishimatsu and Itazawa 1993) .
Lungfi sh and polypterids (birchirs) possess true lungs (not gas or "swim" bladders), with pneumatic duct openings in the alimentary canal (Graham 1997) . Of these, the African (Propterus sp.) and South American (Lepidosiren sp.) lungfi sh are obligate air breathers (Bassi et al. 2005; Graham 1997 ).
Responses to Hypoxia
At the onset of a hypoxic event or upon entering a hypoxic environment, the fi sh's physiological goal is to continue to provide energy and oxygen to the brain. Freshwater cyprinids (carps, goldfi sh) respond by increasing blood glucose; this supports the production of glycolytic adenosine triphosphate (ATP), which in turn increases cerebral blood fl ow through its vasodilation effects. An increase in hematocrit (which increases the blood's oxygen-carrying capacity; Routley et al. 2002; Söderström et al. 1999 ) and the inhibitory neurotransmitter gamma-aminobutyric acid (GABA, which contributes to neuroprotection; Mulvey and Renshaw 2009) also occurs. In contrast, the epaulette shark (Hemiscyllium ocellatum) shows no increase in glucose, hematocrit, or GABA levels (Mulvey and Renshaw 2009; Routley et al. 2002; Söderström et al. 1999) ; instead, vasodilation occurs, as indicated by a drop in both blood pressure (up to 50%, but it is not adenosine mediated) and heart rate. The result is the maintenance of cerebral blood fl ow, but it is not increased as is the case with teleosts (Söderström et al. 1999) . Although blood glucose remains low in the dogfi sh (Scyliorhinus canicula) during hypoxia in the laboratory (Butler et al. 1979) it is not clear whether the response of dogfi sh or other elasmobranchs to hypoxia is otherwise similar to that of the epaulette shark.
Few marine species have evolved adaptations for hypoxic environments other than surface piping or migrating from the area. These species may therefore be less tolerant of hypoxic conditions during anesthesia than the freshwater species discussed above (Rothwell et al. 2005) . Notable exceptions do exist, however, particularly among species that inhabit tidal zones. Among teleosts, the tarpon (Megalops atlanticus) is able to cruise in low-oxygen waters by gulping surface air, while the oyster toadfi sh (Opsanus tau) can tolerate 20 hours of anoxia at 22°C in the laboratory (Ultsch et al. 1981) . Where elasmobranchs are concerned, studies have shown that the torpedo ray (Torpedo marmorata ; Hughes 1978) , Pacifi c spiny dogfi sh (Squalus acanthias; Sandblom et al. 2009) , and epaulette shark (Mulvey and Renshaw 2009; Routley et al. 2002; Söderström et al. 1999 ) all tolerate hypoxic conditions in the laboratory. The epaulette shark responds to hypoxia (e.g., on shallow reef platforms during low tide) by entering a phase of metabolic and ventilatory depression (Mulvey and Renshaw 2009; Routley et al. 2002; Söderström et al. 1999) .
Understanding the range of respiration in fi sh species is important for two reasons. First, immersion drug uptake and induction rate are linked to oxygen demand. For fi sh that depend primarily or entirely on dissolved oxygen 3 Abbreviations used in this article: DO, dissolved oxygen; MS-222, tricaine methanesulfonate (DO 3 ) in water, induction rates are shorter compared to those of air-breathing species (Hseu et al. 1997) . Responding to confi nement or hypoxic anesthetic baths, the latter pull air from the water surface and reduce or temporarily stop opercular movement, and the decreased branchial contact with the water results in a slower rate of anesthetic uptake (Hseu et al. 1997) . For this reason injectable anesthetics are useful in species capable of aerial respiration (Bruecker and Graham 1993) . Second, although many fi sh that use an accessory respiratory organ retain gills for aquatic gas exchange, effective gill tissue is so minimal in some species (e.g., channids, lepidosirenid lungfi sh, and clariids or walking catfi sh) that they will "drown" if denied access to atmospheric air (Ishimatsu and Itazawa 1993; Peters et al. 2001) . Thus, regardless of anesthetic route, these species must remain in very shallow water, or on a moist substrate, until suffi ciently recovered to reach the water/air interface under their own power.
Integument
Although most fi sh have scales, there is marked variation in their distribution and structure, and this variety has implications for the hand injection of drugs, especially for species with large or hard scales or protective denticles.
For many fi sh the skin is a respiratory organ, responsible for up to 30% of oxygen uptake in some species (Bruecker and Graham 1993) ; most marine species in particular have well-vascularized skin capable of signifi cant gas exchange (Ishimatsu and Itazawa 1993) . Younger fi sh, regardless of species, tend to have thinner and less scaled skin, which permits greater oxygen uptake (Myskowski et al. 2003) . And fi sh species that start out as larvae lacking gills require skin respiration until differentiation of gill lamellae is complete (Oikawa et al. 1994) .
Skin is also a route for immersion drug uptake (and presumably drug excretion) and in some species may actually be more effi cient than other respiratory organs-in the electric eel (Electrophorus electricus), for example, quinaldine uptake across the skin was higher than through the gills (Brown et al. 1972) .
Metabolism
Most fi sh are ectothermic, and lower temperatures are usually associated with prolonged induction and recovery times, with the converse true at higher temperatures (Detar and Mattingly 2004; Gelwicks and Zafft 1998; Gomes et al. 2001; Peters et al. 2001; Stehly and Gingerich 1999) . During immersion anesthesia this relationship is primarily related to an altered respiratory rate. And because the blood acid-base status of fi sh is temperature dependent, increased temperature leads to acidemia and hypercapnia that stimulate hyperventilation, which in turn decreases induction and recovery times for drugs taken up or eliminated through the gills (Aguiar et al. 2002; Stehly and Gingerich 1999) .
Some fi sh (e.g., tuna and other members of the Scombridae family; mako shark, Isurus oxyrinchus; porbeagle shark, Lamna nasus) have evolved various degrees of endothermy and have the capacity to conserve metabolic heat and elevate tissue temperature above the ambient temperature (Blank et al. 2004; Brill and Bushnell 2001; Bushnell and Jones 1994; Cooper et al. 1994; Muñoz-Chápuli and Satchell 1999) . In general, endothermic species exhibit an increased rate of anesthetic uptake and metabolism compared to similarly sized ectothermic species.
Most fi sh have an anatomic separation between aerobic, slow-oxidative muscles and anaerobic, fast-twitch, glycolytic muscles. In many species regional heterothermy exists, with a distinct pattern of highly oxygenated slow-oxidative muscle running along the midline of the body (Bernal and Graham 2001; Totland et al. 1981; Williams et al. 2004) . Given the increased capillarization, injection of anesthetic agents into this region may result in more rapid induction times compared to injections administered elsewhere.
Many drugs undergo hepatic biotransformation. Compared to other fi sh, elasmobranchs have proportionally large fatty livers (up to 23% body weight with as much as 80% lipid content) (Holmgren and Nilsson 1999) ; the increased hepatic cellular exposure and high lipid content may result in marked differences in drug pharmacodynamics between elasmobranchs and other fi sh.
Environmental and Other Factors
Temperature
In addition to its effects on metabolism, temperature infl uences DO concentrations. At higher temperatures, DO in the water decreases (Harms 2003) , an effect that can exacerbate anesthetic-induced hypoxia.
pH
The pH of immersion anesthetic solutions infl uences their effi cacy; specifi cally, a drop in the pH generally decreases effi cacy because the increased ionization interferes with absorption (Ross and Ross 1984) . Immersion anesthetics that are acidic in solution require buffering agents to neutralize the pH and thus both promote effi cacy (Ferreira et al. 1984) and prevent metabolic acidemia, a condition precipitated by anesthetic-induced hypoxemia and anaerobic metabolism. Saltwater, with its higher pH and greater natural buffering capacity compared to freshwater, may not require the addition of buffering agents (Harms and Bakal 1995; Harms 1999; Oikawa et al. 1994; Ross 2001; Ross and Ross 1984) depending on the dose of immersion agent, size and activity of the fi sh, and number of fi sh being anesthetized in the same container. Erring on the side of caution, it is advisable to at least check the pH of the anesthetic container after the addition of the drug to determine whether buffers are indicated.
Nitrogenous Compounds
Nitrogenous compounds (e.g., ammonia and nitrite) can damage or alter gill morphology and these changes can have several impacts. They may affect uptake and clearance of inhalant anesthetics. They may compromise oxygen uptake and thus affect metabolism of the anesthetic agents and lead to acidemia. Last, marked elevation of nitrite may result in methemoglobinemia, which reduces the oxygen-carrying capacity of blood.
Drug Concentration/Dosage
Regardless of water temperature, a higher drug concentration (for immersion agents) or dosage usually (but not always) decreases induction and increases recovery times (Hseu et al. 1997 (Hseu et al. , 1998 . Furthermore, dosing requires careful attention as some immersion drugs (e.g., MS-222; more on this drug below) continue to increase in the brain and muscle despite blood equilibration (Ross 2001) . Thus an initially satisfactory drug dosage can produce progressively deeper anesthesia and even respiratory arrest, even when the fi sh is recovering in anesthetic-free water (Ross 2001) .
Drug Administration Methods
General Suggestions
Before anesthetizing an unfamiliar species, we recommend performing a literature review using terms such as "physiology," "anatomy," "site fi delity," "fecundity," along with the scientifi c name of the species to identify studies that required chemical restraint. The use in adult fi sh of dosages and regimens from the literature requires careful consideration as many studies use young or small fi sh. The anesthetic regimen for an unfamiliar species should be tested through recovery using one or a small group of fi sh before applying it to a larger number of fi sh (Harms and Bakal 1995; Ross 2001; Stetter 2001) .
Preanesthetic Preparation
When possible, baseline behavioral parameters (i.e., 1.
ventilation, caudal fi n stroke rate, and overall activity level) should be recorded. Withholding the animals' food for 12 to 24 hours limits 2.
regurgitation (which clogs gill rakers) and decreases nitrogenous waste production (Harms and Bakal 1995; Stetter 2001 ).
Containers with adequate water for transportation, in-3. duction, maintenance, recovery, and possible required water changes should be readily available (Harms 1999; Stetter 2001 ). The physical (e.g., temperature) and chemical (e.g., pH, 4. salinity) variables of water used should match those of the fi sh's source water. Dissolved oxygen should be maintained at >5 ppm (mg/l); the ideal is 6-10 ppm (Harms 1999; Stetter 2001 ). Out-of-water procedures must include a plan for prevent-5.
ing drying of the skin, fi ns, and eyes. Arrangements may include coverage with clear plastic drapes and regular rinsing of tissues with water from a bulb syringe or a small portable atomizer (Harms 1999; Ross 2001) . Personal protective gear must be available. Use of a 6. respiratory mask may be appropriate when measuring powdered anesthetics, and the use of gloves limits systemic absorption and reduces the potential for zoonotic disease transmission.
Immersion Anesthesia
Immersion anesthesia in fi sh is analogous to gaseous inhalant anesthesia in terrestrial animals (and is referred to as inhalant anesthesia in some of the literature). The fi sh ventilates the anesthetic in solution, which enters the bloodstream through the gills and/or accessory respiratory organs and/or the skin and then passes rapidly to the central nervous system (CNS). Both gill tissue and skin contain large amounts of lipid, so the effi ciency of uptake of immersion agents across these surfaces is directly related to the drug's lipid solubility (that of MS-222, for example, is relatively high). Skin thickness and scalation also affect uptake, with thinner skin and loosely scaled or scaleless surfaces favoring drug uptake compared to thicker skin or densely packed scaled surfaces (Ferreira et al. 1984) . When the fi sh is placed in drug-free water, it excretes drugs or their metabolites via the gills and presumably accessory respiratory organs; some elimination also occurs through the kidneys and skin (Ross 2001; Walsh and Pease 2002) . It is important to note that excreted water-soluble drugs or metabolites may be reabsorbed through the body surface and gills while being simultaneously metabolized and eliminated (Oikawa et al. 1994) .
Immersion drugs must be water soluble or use a watersoluble solvent as a vehicle. It is preferable to use water from the fi sh's tank to make the anesthetic solution. For simple, short procedures the drug concentration is either prepared in an aerated container to which the fi sh are transferred or added directly to the water containing the fi sh. The latter approach requires the addition of a buffer before drug administration to minimize acute drops in pH (Harms 1999; Ross 2001) . Ideally, spontaneous ventilation is maintained during short procedures. When immersion is impractical or dangerous to handlers (e.g., for large fi sh), drugs in solution may be applied directly to the gills.
The use of an artifi cial ventilation system is necessary for procedures that last more than 10 minutes, those that involve debilitated fi sh or slow-recovering species, and all but the shortest out-of-water procedures. All of these conditions require holding the fi sh in shallow water or placing it on a fenestrated surface (in lateral recumbency or upright/upside down in a foam holder), with a bifurcated pipe or mouthpiece placed in the buccal cavity to deliver aerated anesthetic solution across the gills (Figure 1) .
Nonrecirculating or recirculating systems are available. A nonrecirculating system, in its simplest form, uses an IV fl uid bag with a drip set value (Figure 2) . Aeration of the anesthetic water with an air stone in the nonsealed IV bag ensures near-saturation of oxygen and removal of dissolved CO 2 . Used water is collected but not recycled (Harms 1999; Ross 2001; Stetter 2001 ). This system is suitable for small to medium-sized fi sh depending on the reservoir volume, drip set tube diameter, and rate of fl uid delivery.
Recirculating systems enable both the delivery of anesthetic water from a reservoir to the gills and the recycling of the effl uent (Figure 3) , either manually or with a submersible pump. A valve on the tube leading to the mouth controls the fl ow rate. Minimum effective fl ow rate during fi sh anesthesia has not been determined; 1 to 3 liters/min/kg is recommended. Low delivery rates fail to keep the gills wet and reduce gas exchange; high fl ow rates result in alimentary anesthetic delivery and gastric dilation. An air stone provides oxygenation. Recirculating systems are appropriate for large fi sh, where cost and wastewater concerns require conservation of anesthetics and water (Harms 1999; Ross 2001; Stetter 2001) .
During immersion anesthesia, adjustment of the drug concentration in response to anesthetic depth is diffi cult. One option is to prepare measured volumes of anesthetic-free water and concentrations of anesthetic solution in separate bags or reservoirs for use in either recirculating or nonrecirculating systems. Alternatively, a bulb or other syringe enables rapid delivery of small amounts of anesthetic fl uid directly to the gills without disconnecting the fi sh from the system Figure 1 Goliath grouper (Epinephelus itajara) positioned on bubble wrap in a foam holder during tricaine methanesulfonate (MS-222) anesthesia. The bifurcated mouthpiece placed in the buccal cavity delivers oxygenated anesthetic water to both sets of gill arches. (Harms 1999) . The fl ow is usually normograde to achieve optimal gas and anesthetic exchange. Though retrograde fl ow is sometimes necessary (e.g., in oral surgery or because of species anatomical variations), it nullifi es the normal countercurrent exchange mechanism and may damage the gills.
Parenteral Anesthesia
In addition to immersion methods, anesthetics can be delivered orally, intravenously (IV), intracoelomically (ICo), and intramuscularly (IM). With the exception of metomidate (see below), there have been few studies on oral anesthetics (e.g., Hansen et al. 2003; Harms and Bakal 1995; Steers and Sherrill 2001) and this route likely has limited use because precise dosing is diffi cult and the rate and degree of absorption are uncertain (Harms 2003) .
IV injection results in rapid induction and usually a short duration of effect, but it has the disadvantage of requiring either manual restraint or prior administration of drugs by another route to allow IV access (Fleming et al. 2003; Hansen et al. 2003) .
ICo delivery, although effective, has two disadvantages: an increased risk of visceral damage (although this can be Figure 2 A simple nonrecirculating system using an IV bag and drip set. Gravity-dependent fl ow rate is controlled by the drip set valve. Used water is collected (in the tank below) but not recycled. This system is suitable for small to medium-sized fi sh depending on the volume of the reservoir, the drip set tube diameter, and the rate of fl uid delivery. minimized by inserting the needle at an acute angle directed anteriorly) and inconsistent induction times, because the drugs must pass through the serosal surface.
The most common parenteral route is IM injection by hand syringe, pole syringe, or a darting system (Harms 1999; Harvey et al. 1988; Williams et al. 1988) . When possible, the recommended site for IM administration is the dorsal saddle, an area that surrounds the dorsal fi n and extends laterally to just above the lateral line, from the operculum or posterior gill slit caudal to a point approximately one-third the distance between the dorsal fi n and the caudal peduncle. IM injections often result in leakage as the needle is withdrawn and the surrounding muscles contract (Harms and Bakal 1995; Peters et al. 2001 ); drug loss is preventable by holding the fi sh in hand, placing the needle directly on the dorsal midline between the epaxial muscles, and then laterally inserting it into a muscle bundle (Harms and Bakal 1995) . It is important to note that (1) skeletomuscular movement helps blood and lymph circulate (Gruber and Keyes 1981) , so anesthetic induction time may be delayed in sedentary species, and (2) injection volumes are often large and may contribute to sterile abscess formation in the musculature (Tyler and Hawkins 1981) .
Regardless of route, parenteral anesthetics often do not provide adequate sedation or anesthesia and so require supplemental immersion anesthesia. In addition, ventilatory support is necessary with parenteral anesthetics, particularly if recovery is prolonged (Harms 1999) .
Monitoring
Anesthetic Depth
Investigators have used various schemes to assess anesthetic depth in fi sh (Detar and Mattingly 2004; Myszkowski et al. 2003; Oikawa et al. 1994) ; criteria include activity, reactivity to stimuli, equilibrium (righting refl ex), jaw tone, muscle tone, and respiratory and heart rates. Broad stages include sedation, narcosis or loss of equilibrium, and anesthesia, with each stage subdivided into light and deep planes (Harms 2003; Stetter 2001) . But depending on the species, drug, and dosage, some stage components are not available (Harms 1999; Stetter 2001) . Conversely, some signs attributed to drug effect are instead responses to stress. For example, Gulf of Mexico sturgeon (Acipenser oxyrinchus de soti) often turn to a ventral/dorsal position when stressed (Fleming et al. 2003) , so loss of the righting refl ex is not appropriate to determine anesthetic stage in this species.
With proper dosing, induction with immersion drugs usually occurs within 5 to 10 minutes, but may take longer via other routes. Induction is marked by decreases in caudal fi n strokes, swimming, respiratory rate, and reaction to stimuli; the drop in caudal fi n stroke activity is usually the fi rst sign, followed by loss of equilibrium and response to stimuli. At surgical anesthesia there is total loss of muscle tone and a further decrease in respiratory rate. A fi rm squeeze at the base of the tail can be an effective way to determine response to stimuli: if the animal does not respond, general anesthesia has taken effect (Harms 2003; Stetter 2001) .
Some species go through a short excitement phase during immersion induction and may traumatize themselves (Harms 1999; Stetter 2001) . And fi sh exposed to high drug concentrations may exhibit rapid and repeated fl aring of the opercula, with a "coughing" refl ex to fl ush the chemical irritant from the branchial cavity.
Cardiopulmonary Activity
Respiratory and cardiac rates usually decrease with increased anesthetic dosage and duration. But in some species (e.g., tuna) opercular movement is minimal or even nonexistent due to their mode of ventilation (ram ventilation). These fi sh maintain adequate ventilation, at least in the short term, through the passage of oxygenated water over their gills (respiratory arrest in fi sh can precede cardiac arrest by an extended period of time; Harms 1999).
In species with thin pliable body walls and proportionally large hearts, heart beats are directly observable (Harms and Bakal 1995; Harms 1999) . For most species, however, monitoring of the heart rate requires the use of cardiac ultrasonography, Doppler fl ow probes, or electrocardiography (ECG) (Harms and Bakal 1995; Harms 1999; Ross 2001) . Ultrasonography and Doppler probes are placed either into the opercular slit (for medium to large fi sh) or directly over the heart (for smaller specimens and small-scaled/scaleless species; Figures 4 and 5) . ECG entails lightly clamping electrodes to the surface of the fi ns (the pectoral and anal fi ns are a good combination) (Ross 2001) ; alternatively, subcutaneous placement of needle electrodes minimizes skin trauma, reduces the chance of grounding out the ECG signal by contact with a wet external surface, and improves signal quality Ultrasonography is useful for monitoring heart rate in fi sh. In specimens of suffi cient size, the probe can be placed in the opercular slit as in this rainbow parrotfi sh (Scarus quacamaia). In smaller specimens or small-scaled/scaleless species, the probe is placed directly over the heart.
Figure 5
Doppler fl ow is useful for monitoring heart rate in fi sh, with probes placed in the opercular slit (for large and medium-sized fi sh) or directly over the heart (for smaller specimens and smallscaled/scaleless species). This fi gure demonstrates placement of the probe in the opercular slit of an African cichlid (Protomelas insignis). (Harms 1999) . Studies have not shown that pulse oximetry is effective for measuring hemoglobin saturation in fi sh (Harms 1999; Ross 2001) .
Although a fi sh may appear to be ventilating well, bradycardia and an increased resistance to gill capillary fl ow (as erythrocytes accumulate in the capillary bed and become swollen) may cause hypoxemia (Tyler and Hawkins 1981) . Useful variables in detecting hypoxemia include gill color (pallor indicates hypoxemia, hypotension, hypovolemia, or asystole) and fi n margin color (pallor indicates hypoxemia, hypotension, or peripheral vasoconstriction) (Harms 2003; Stetter 2001) . In large fi sh, an effective way to monitor respiratory effi ciency is periodic blood gas sampling to determine oxygenation, carbon dioxide, and pH. Venous samples are easier to collect and provide useful information about physiological trends. Other blood variables used to assess metabolic status include hematocrit, glucose, and lactate.
Water Quality
It is critical to monitor water quality in order to reduce anesthetic morbidity and mortality. Assuming aeration, DO, pH, and temperature are appropriate, the greatest concern is ammonia concentrations. These rise-and buffering capacity decreases-during prolonged procedures and when fi sh are sequentially anesthetized in a recirculating anesthetic system. Ammonia toxicity is greater in more alkaline water (e.g., marine systems). Ammonia is easy to measure with tankside kits; or the anesthetist may use other indicators of deteriorating water quality such as surface foam formation due to increased protein from fi sh slime (Harms 1999) . For species that are facultatively ureotelic and ureogenic (e.g., Gulf toadfi sh, Opsanus beta), excreting most nitrogenous waste as urea in response to stressors (e.g., anesthesia) (Gilmour et al. 1998) , the measurement of ammonia concentrations as a guide to water quality is inaccurate and the handler must rely on the other parameters.
Correction of declining water quality during anesthesia requires a partial water change, by adding either water containing a known anesthetic concentration or, when reducing anesthetic depth, a known volume of clean water. One of the authors (DLN) routinely changes out up to 50% of water in the anesthetic chamber at a time without negative effects. When using a recirculating system or the same water for multiple fi sh, the frequency of water changes needed will depend on the size of the fi sh (in proportion to water volume) and waste production. For example, one author (DLN) changes out 100% of the anesthetic bath after 3 to 4 adult southern stingrays (Dasyatis americana) have been anesthetized in a 200 liter container (as long as visible waste material is not signifi cant), but will anesthetize 6 to 12 grunts (15-30 cm) in an 80 liter cooler before changing the water. It is particularly useful to look for the buildup of bubbles on the surface of the water, as these indicate increasing protein levels from waste production and the need for at least a partial water change.
Recovery
With immersion anesthesia, recovery occurs when the fi sh is placed in anesthetic-free water (Ross 2001) , and for injectable α 2 -agonists reversal drugs are available (Harms 1999; Horsberg et al. 1999; Snyder et al. 1998; Williams et al. 2004 ). Although recovery occurs by different mechanisms, transfer to a new water container is advisable after any route of anesthesia as some of these drugs and their metabolites may be excreted into the water and reabsorbed through the gills and/or skin. The recovery water is aerated and the fi sh's mouth oriented toward water fl ow. In an artifi cial ventilation system, anesthetic-free water is passed over the gills until spontaneous ventilation resumes; alternatively, the fi sh is pulled forward through the water with its mouth open. Dragging the animal backward is inadvisable as retrograde fl ow provides ineffi cient oxygen and anesthetic exchange and may cause gill damage.
Most fi sh fully recover from inhalant anesthetics within 5 minutes; recoveries extending more than 10 minutes indicate an excessive anesthetic dosage or a compromised animal (Ross 2001; Stetter 2001) . In comparison, recovery from oral and parenteral agents is more variable. As the fi sh recovers, respiration increases, muscle tone returns, fi n movements resume, and the fi sh swims with progressively less ataxia until it regains full equilibrium.
Some fi sh go through an excitement phase (sometimes quite severe) during recovery and should be prevented from escaping from the tank (Harms 1999 ) with the use of lids, nets, foam pads, or other barriers. Individual fi sh may even require manual restraint during this period to prevent damage to their eyes and body. In either case, the handler should take precautions to avoid injury from the fi n rays and teeth of certain bony fi sh and from the stingers (rays), teeth, and skin of some elasmobranchs.
Resuscitation
Marked hypoventilation (bradypnea) is usually not a cause for alarm. If cardiac output is steady and oxygenated water is fl owing appropriately over the gills, tissue gas exchange is probably adequate, but decreasing the anesthetic concentration or moving the fi sh to anesthetic-free water may be appropriate (Stetter 2001) . In either case, the anesthetist should take advantage of the buccal fl ow/heart rate refl ex, which causes the heart rate to accelerate in response to an increase in water fl ow through the buccal cavity. The resulting increase in gill blood fl ow hastens both elimination of the inhalant drugs and recovery. These effects occur naturally after the gentle movement of the fi sh forward through the water until spontaneous ventilation returns (Ross 2001 ). This method is also effective with bradycardia.
Unresponsive fi sh may require the administration of fl uids, doxapram, and/or forced ventilation. One author (DLN) has observed a positive response to doxapram administration (5 mg/kg IV or ICo) in several cases of respiratory arrest. However, doxapram can be a marked stimulant in elasmobranchs, causing them to become extremely excited and dangerous (Stoskopf 1986 ). Other traditional mammalian emer gency drugs (e.g., epinephrine, corticosteroids) may be given in the case of physiological collapse, although the effects are not well understood. Table 1 provides a summary of commonly used sedative, analgesic, and anesthetic agents used in fi sh. We describe the applications, impacts, and limitations of each in the following sections. Tricaine methanesulfonate (MS-222 3 ) is a benzocaine derivative that is absorbed across the gills (and the skin in some species), biotransformed in the liver and probably kidney, and cleared primarily through the gills, with additional metabolites eliminated in urine and bile (Harms 1999; Maren et al. 1968) . Powder is directly mixed into the anesthetic chamber or administered as a stock solution of 10 g/l (10,000 mg/l). Both powder and liquid are unstable in light and require storage in a dark container. Oily residues or a change in color of buffered stock solutions indicate the presence of a desulfonation product and decreased potency. MS-222 is more effective and safe in its neutralized form, which is achieved by buffering the solution to the pH of the fi sh's holding water. Sodium bicarbonate is primarily used, but other buffers are also effective (e.g., imidazole, sodium hydrogen phosphate, sodium hydroxide, and calcium carbonate). Exact amounts of sodium bicarbonate are measured or the powdered buffer is incrementally mixed into the anesthesia chamber until the solid no longer dissolves, indicating saturation (Harms 1999; Oikawa et al. 1994; Roubach et al. 2001; Stetter 2001) .
Anesthetic Drugs
MS-222 is not effi cacious for all fi sh. For example, in Gulf of Mexico sturgeon it is minimally effective at providing immobilization even at 400 mg/l (4 to 10 times the dosage for most species) (Fleming et al. 2003) .
MS-222 can be associated with hypoxemia resulting from drug-induced hypoventilation (Davis and Griffi n 2004; Harms and Bakal 1995; Oikawa et al. 1994) , and the safety margin is narrower for young fi sh in warm, soft water (Harms 1999; Roubach et al. 2001 ). MS-222 may also cause reversible retinal defi cits in fi sh and humans (Bernstein et al. 1997; Sladky et al. 2001) .
Benzocaine
Benzocaine, the parent compound of MS-222, is similar in pharmacology but less acidic and much less water soluble, features that may account for its usefulness in species sensitive to MS-222 (e.g., striped bass, Morone saxatilis) (Hseu et al. 1998 ). The compound requires advance preparation of a stock solution in ethanol or acetone (100 g in 1 liter) or propylene glycol, with storage of the solution in a dark bottle at room temperature (Harms and Bakal 1995; Iversen et al. 2003) .
Other advantages of benzocaine include low toxicity for humans (at the concentrations used for fi sh) and its removal from facility effl uents using activated carbon fi ltration; but even without fi ltration, breakdown in water occurs in approximately 4 hours, making environmental contamination less likely. Exposure also does not impair fi sh growth or reproductive capacity Hseu et al. 1998; Tyler and Hawkins 1981) . As with all drugs, effi cacy and sensitivity to benzocaine vary with the species and dosage . One major concern is the drug's fat solubility, which may result in prolonged recovery in older and gravid fi sh (Iversen et al. 2003) .
Clove Oil, Eugenol, Isoeugenol, and Aqui-S
Clove oil is a mixture of compounds: phenolic eugenol (which accounts for 85-95% of the active ingredients), isoeugenol, and methyleugenol. Commercially available clove oil has approximately 84% eugenol, but it is possible to purchase 100% eugenol. Aqui-S™ contains primarily isoeugenol (Iversen et al. 2003; Kildea et al. 2004 ) and is not available in the United States. Clove oil and eugenol are incompletely water soluble, particularly at cold temperatures. A 1:10 mixture of either in 95% ethanol yields a 100 mg/ml stock solution (Harms 2003) .
Clove oil results in more rapid induction times and consistent anesthesia compared to other anesthetics (Bressler and Ron 2004; Detar and Mattingly 2004; Sladky et al. 2001 ), but longer recoveries (Detar and Mattingly 2004; Sladky et al. 2001) . Other reported advantages include efficacy at a range of temperatures, availability, low cost, and handler safety (Bressler and Ron 2004; Detar and Mattingly 2004) , and one study claimed increased safety for fi sh compared to other immersion drugs (Detar and Mattingly 2004) . However, another study reported a narrow safety margin (compared with MS-222) in the red pacu (Piaractus brachypomus; Sladky et al. 2001) , and one author (DLN) has seen increased sensitivity to eugenol and Aqui-S in preliminary studies with southern stingrays. Possible explanations for ventilatory failure and medullary collapse observed in the red pacu include neurotoxic or hepatotoxic effects similar to those in mammals (Sladky et al. 2001) , or the fact that eugenol, an oil, coats gill epithelia and may block gaseous diffusion (Sladky et al. 2001 ). In addition, researchers have described mild gill necrosis from repeated exposure to low doses of eugenol (Afi fi et al. 2001) .
Although clinical studies have demonstrated analgesic effects of eugenol in humans (Keene et al. 1998) , there is no proof of such effects in fi sh (Sladky et al. 2001) . Red pacus anesthetized with eugenol were more likely to react to a hypodermic needle puncture than fi sh anesthetized with MS-222, raising the question of the appropriateness of the clove oil complex for invasive or otherwise noxious procedures.
Metomidate
Metomidate is a nonbarbiturate imidazole available for investigational use in the United States (Harms 1999 ) and sold in Canada under the trade name Marini™. It is readily water soluble and requires storage in tight light-protected containers.
Metomidate suppresses the cortisol response to anesthesia by blocking adrenocorticotropic hormone (ACTH) stimulation of steroidogenesis, even after ICo injection of exogenous ACTH. The suppression occurs by a direct effect on the interrenal gland and the mitochondrial cytochrome P 450 -dependent enzymes that catalyze cortisol synthesis (Davis and Griffi n 2003; Iversen et al. 2003; Small 2005) . Cortisol synthesis blockade may cause the fi sh to transiently darken, possibly because of reduced cortisol production terminating the negative feedback loop on ACTH synthesis. As ACTH synthesis is linked to melanocyte-stimulating hormone production, both compounds increase with the associated color change (Harms 1999; Harms and Bakal 1995) .
Metomidate is useful for sedation and anesthesia for minor procedures as well as limiting transport trauma, as dosages that suppress the cortisol stress response still allow maintenance of equilibrium (Davis and Griffi n 2004; Harms 1999) . However, it is a hypnotic and does not induce general anesthesia, as is evident in the maintenance of opercular respiration for twice as long as with other inhalants at the effective concentration (Mattson and Riple 1989) and in muscle fasciculations (indicating incomplete relaxation) at low doses (Harms 1999) . Furthermore, metomidate is probably a poor analgesic and should not be used alone for major surgical or noxious procedures (Hansen et al. 2003; Harms 1999) . Gouramis (Osphronemidae) are very sensitive to metomidate, and its use in cichlids (Cichlidae) in water of pH < 5 is contraindicated (Harms 1999) .
2-Phenoxyethanol
2-Phenoxyethanol (2-PE) is a moderately water-soluble clear or straw-colored oily liquid widely used for sedation (particularly in fi sh transportation) and anesthesia (Hseu et al. 1996 (Hseu et al. , 1997 Ross 2001) . Advantages are low cost and the fact that no pH change occurs with the addition of 2-PE to seawater (Hseu et al. 1998 ). However, 2-PE produces hypoventilation and provides poor analgesia (Oswald 1978) . Also, sustained and regular exposure to 2-PE solution causes a neuropsychological syndrome in some handlers (Hseu et al. 1998) .
Quinaldine and Quinaldine Sulphate
Quinaldine, a quinoline derivative, is a yellowish oily liquid that must be dissolved in acetone or alcohol prior to mixing in water. Quinaldine sulfate (QS) is a strongly acidic, highly water-soluble powder that must be buffered and administered as a stock solution (10 g/l). Due to high lipid solubility, quinaldine tends to accumulate in the brain more than QS (Harms 1999; Hseu et al. 1998; Ross 2001) and may result in deeper anesthesia compared with QS, factors that may make it less safe than QS. Like MS-222 and most inhalants, quinaldine and QS depress the CNS sensory centers. Unlike MS-222, neither drug is metabolized by fi sh and both are excreted entirely unchanged (Harms 1999; Hseu et al. 1998) .
Advantages of the use of QS in fi sh are low cost, effectiveness at very low concentrations, and short recovery time. But despite the drug's purported low toxicity and wide safety margin, mortality occurs in some species and quinaldine can be an integumental and ocular irritant (Harms and Bakal 1995; Kumlu and Yanar 1999; Ross and Ross 1984) . Several studies demonstrate that fi sh exposed to quinaldine or QS retain a strong refl ex response to being touched, even when they have lost equilibrium and are "anesthetized." This potential lack of analgesia makes both drugs inappropriate for surgical or similarly noxious procedures (Cullen 1996; Harms 1999; Kumlu and Yanar 1999) .
To reduce toxicity and increase effi cacy and analgesia, some researches have combined diazepam in a bath with QS, so that fi sh enter a deeper anesthetic plane at lower QS dosages (Kumlu and Yanar 1999) .
Azaperone
Azaperone reduces an animal's response to environmental stimuli without motor impairment or sedation. Preliminary studies in piked dogfi sh (Squalus acanthias) have shown that the most effi cacious application of azaperone is directly over the gills (IM injection produces no effect) (Latas 1987) . The advantages of using azaperone in fi sh include uninterrupted swimming patterns, normal gill ventilation, and normal cardiovascular function. Azaperone may also be useful for animals that are prone to panic, aggression, and self-induced trauma (Latas 1987) .
Isofl urane and Halothane
There are few published studies evaluating chlorofl uorocarbon-based anesthetics in fi sh (Dunn and Koester 1990; Stetter 2001) . Their use requires care as anesthetic depth is diffi cult to control and the drug's insolubility in water results in localized higher concentrations that may cause overdosage. In addition, volatilization and diffi culty in scavenging waste gas are hazardous to personnel (Harms 1999; Ross 2001) . Given the disadvantages associated with the use of isofl urane and similar drugs, a number of researchers and clinicians recommend them only as a last resort for anesthesia, for euthanasia, or not at all (e.g., Harms 1999; Ross 2001) .
Oxygen
Oxygen is a sedative for some elasmobranch species. Oxygenated water is fl ushed across the gills by bubbling 100% oxygen in the fl ow of water directed into the animal's mouth. But prolonged exposure to elevated oxygen depresses ventilation and produces hypercapnia and potentially life-threatening acidemia (Spotte 1992) .
Injectable Anesthetics
Ketamine Hydrochloride
Ketamine, used alone or in combination with α 2 -agonists (Harms 1999) , is effective for a number of species (Williams et al. 1988 ) and for short procedures (Bruecker and Graham 1993; Oswald 1978) . The most common injection route, IM, requires high doses when used alone (Bruecker and Graham 1993; Fleming et al. 2003; Williams et al. 1988) ; IV administration entails dosages of one-third to one-half those for IM delivery and reduces oxygen demand during handling in several species (Bruecker and Graham 1993; Oswald 1978) .
Ketamine alone has a species-specifi c effect in fi sh often characterized by incomplete anesthesia, periods of apnea, and prolonged recovery with excitement (Bruecker and Graham 1993; Graham and Iwama 1990; Oswald 1978) . Elasmobranchs are more sensitive than teleosts and occasionally have seizure-like muscle spasms (Stoskopf 1993) . To reduce dosage-related apnea and muscle spasms and to improve anesthesia, ketamine is often combined with the reversible α 2 -adrenergic agonist medetomidine (see next section). This combination provides safe and effective anesthesia in some species but causes respiratory depression, bradycardia, and incomplete immobilization in others (Fleming et al. 2003; Snyder et al. 1998; Williams et al. 2004) . For these reasons, ketamine or ketamine/medetomidine (K/M) is more appropriate as an aid to restraint or capture than as a substitute for inhalant anesthesia during major procedures.
Medetomidine
Medetomidine is effective as an immersion drug in rainbow trout to produce sedation (but not analgesia), after which atipamezole is added to the recovery water at six times the medetomidine concentration (Horsberg et al. 1999) . Ordinarily, however, medetomidine is combined with ketamine and administered IM, again with the use of atipamezole to reverse the effects in both teleosts and elasmobranchs (Snyder et al. 1998; Williams et al. 2004) . One of the authors (MAS, unpublished observations) has investigated the use of medetomidine with ketamine in several shark species and found that there appears to be great variation between species in their responses to similar dosages under the same conditions.
Xylazine
The use of xylazine with ketamine has provided safe and effective anesthesia in sharks (Andrews and Jones 1990; Stoskopf 1986 Stoskopf , 1993 , although xylazine variably alleviates the muscle spasms that can occur with ketamine use alone (Stoskopf 1993) . However, xylazine can produce apnea (Oswald 1978) and it induces convulsant activity that occurs during teleost induction and recovery, making it diffi cult to ensure artifi cial ventilation because the convulsions frequently dislodge the water supply. In addition, gross ECG disturbances have been detected. For all these reasons, and given the proven usefulness of medetomidine in teleost species, xylazine is not a preferred α 2 -agonist for bony fi sh and is not recommended in salmonids (Oswald 1978) .
Propofol
Propofol use in spotted bamboo sharks (Chiloscyllium plagiosum) resulted in surgical anesthesia with stable respiration and heart rates throughout the anesthetic period (Miller et al. 2005) . In Gulf of Mexico sturgeon propofol IV rapidly induced anesthesia but caused signifi cant respiratory depression, which was addressed by passing oxygenated water across the gills (Fleming et al. 2003) .
Alfaxalone/Alfadolone
A combination steroid, alfaxalone/alfadolone (A/A) mainly depresses CNS activity while leaving the integumentary sensory system operational. This makes it very valuable for research in sensory physiology (e.g., with mechanoreceptors; Peters et al. 2001) . Another advantage of A/A is its cardiac chronotropic and inotropic stimulatory effect with vasodilation of the gill capillaries, which seems to ensure adequate oxygenation of the blood compared to many other anesthetics (Oswald 1978) . As with other drugs, researchers have documented species differences (Harvey et al. 1988 ). For example, in several catfi sh species A/A provided stable surgical anesthesia lasting several hours (Peters et al. 2001) , whereas in two trout species it was diffi cult to fi nd an A/A dose that simultaneously abolished locomotion and preserved ventilation (Oswald 1978) .
Analgesia
Limited information is available about the use of analgesics in fi sh; further study is needed, particularly given the increased interest in the use of analgesics for fi sh in the laboratory and clinical setting.
Drugs listed as an anesthetic for fi sh are often assumed to provide analgesia if they result in complete immobilization of the fi sh. And because fi sh have µ and κ opiate receptors throughout the brain, it is reasonable to expect some effect of opioid treatments in fi sh experiencing noxious stimuli (Harms et al. 2005) . However, the distinction between anesthetic agent (with analgesic properties) and immobilizing drug is not always clear and depends on the properties of a particular drug; it is never appropriate to assume analgesia with all "anesthetics." Certainly, it is possible to determine which drugs provide better immobilization for a particular species by comparing the responses of individual fi sh to noxious stimuli (e.g., needle stick, tail squeeze, handling) when exposed to different "anesthetic" agents. This approach may be appropriate for an investigator who plans to use a particular species regularly in laboratory research.
In one study, the lips of juvenile rainbow trout were injected with 0.1 ml acetic acid, which resulted in an increased opercular rate compared to controls and anomalous behaviors such as rocking and lip rubbing against the substrate and tank sides (Sneddon 2003) . Administration of high morphine dosages signifi cantly reduced the opercular rate and the anomalous behaviors, suggesting that morphine acts as an analgesic or at least antinociceptive in this and presumably other teleost fi sh (Sneddon 2003) . In another study koi carp (Cyprinus carpio) that underwent exploratory celiotomy received butorphanol, ketoprofen, or saline; only the koi injected with butorphanol exhibited no signifi cant differences between pre-and postsurgery caudal fi n beat frequency and vertical position in the water column, a result that suggests a mild behavioral sparing effect compared with the ketoprofentreated and saline control groups (Harms et al. 2005) .
As is the case with mammals, fi sh can become tolerant of morphine, and naloxone reduces its effects (and presumably that of butorphanol) (Rose 2002) . In a study involving an elasmobranch (chain dogfi sh, Scyliorhinus retifer), neither butorphanol nor ketoprofen provided appreciable analgesia in animals that received a noxious stimulus (needle stick in epaxial muscle). It is not clear whether these results represent a fundamental difference between elasmobranch and other fi sh physiology or an insuffi cient dose or frequency (Davis et al. 2006) .
Aside from two studies in which ketoprofen was not effective (Davis et al. 2006; Harms et al. 2005) , there are no published studies on the effectiveness of nonsteroidal antiinfl ammatory drugs (NSAIDs).
Euthanasia
When necessary, overdosage of immobilization drugs is an acceptable means of euthanasia (AVMA 2007) . The most frequent choice is the use of immersion drugs (and particularly MS-222) at fi ve to ten times the anesthetic concentration for a particular species, although injectable agents are also effective (Ross and Ross 1984) . For fi sh that are too large for a bath, the immersion drug is poured directly over the gills (Harms and Bakal 1995) . Maintaining the fi sh in the anesthetic solution for 5 to 10 minutes after cessation of opercular movement (except in some ram ventilating species) usually, but not always, ensures that a fi sh has expired. Cardiac asystole typically lags behind brain death since fi sh myocardial cells use local glycogen stores for energy and do not need blood glucose (Stetter 2001) . The use of Doppler fl ow probes, ultrasonography, or electrocardiography is recommended to confi rm asystole and, to be certain, IV administration (in the heart or caudal vein) of an additional anesthetic drug or pentobarbitone should be performed (Ross 2001) . Alternatively, cranial concussion, spinal transection, or exsanguination are effective methods in a deeply anesthetized fi sh (Harms 1999) .
Although carbon dioxide is often reported as being useful for immobilization, its use has many disadvantages, including diffi culty in controlling concentrations in water, the need for maintaining high oxygen levels, and the occurrence of markedly altered blood gases and acid-base balance (Gelwicks and Zafft 1998; Harms 1999; Prince et al. 1995) . Following immersion in water with a high CO 2 concentration, there is a rapid decrease in blood pH that results in less effi cient oxygen transport to tissues, including the brain. The resulting cerebral hypoxia causes an overall inhibition of spontaneous activity of the CNS and the observed "anesthetic" effect (Gelwicks and Zafft 1998; Harms and Bakal 1995) . Although fi sh appear tolerant of the blood changes and cerebral hypoxia (Gelwicks and Zafft 1998) , several studies point to CO 2 's questionable analgesia and appropriateness for invasive procedures (Prince et al. 1995; Ross 2001) . Many handlers feel that CO 2 should be used only for euthanasia or as a last resort immobilization chemical when noxious stimuli are involved (Harms 1999) .
We encourage the reader to refer to the American Veterinary Medical Association Guidelines on Euthanasia (AVMA 2007; formerly the Report of the AVMA Panel on Euthanasia) for further information about approved and nonapproved methods for euthanasia of fi sh.
Concluding Thoughts
For the researcher, clinician, or technician who handles fi sh, an increasing body of information about the chemical restraint of fi sh is available in journal articles and secondary texts as well as agricultural extension agency pamphlets, instructional course handouts, and similar types of publications. Factors that may be driving this growing knowledge base include increases in three related areas: aquaculture activities, which often require sedation or anesthesia of large numbers of fi sh for transport and handling; requirements or interest in the use of fi sh in research over other vertebrate classes; and trends in the public zoological and aquarium industry to provide improved and advanced veterinary care to their fi sh. In research and display activities, interest in both fi sh welfare and environmental impacts is a motivating factor-collection from the wild is still a major means of marine specimen acquisition, and increased fi sh longevity decreases the need for such collecting. Efforts to ensure fi sh welfare are in aquaculture's best interest as improved welfare tends to correlate with decreased stress and, in turn, better product yield and quality.
As discussed, there is a need for basic information about the effects of the multitude of drugs across the many orders and families of fi sh. It is likely impossible to perform studies on a signifi cant number of species, so the research emphasis should be on species from groups for which there is a dearth of knowledge, to improve extrapolation exercises that will forever be a part of fi sh medicine given the huge number of fi sh species. In particular, information about analgesia and drugs that may be appropriate is noticeably lacking (techniques and drugs used for fi sh euthanasia appear to be adequate and appropriate).
Beyond basic studies, investigations should be directed at bringing the practice of fi sh anesthesia to the level of familiarity and competence evident with other vertebrate classes. It is not uncommon for veterinarians, researchers, and similar personnel to be particularly pleased with themselves when they anesthetize a fi sh for the fi rst time for a short procedure and it recovers. While this indication of an increased interest in fi sh is a positive trend, the profession should not be satisfi ed with this level of performance. If fi sh medicine (and especially surgery) is to advance, it is essential to ensure that fi sh routinely survive medium-to longterm procedures. While lengthy procedures and survival are routine for a few species (e.g., carp), the literature is sparse concerning successful, prolonged surgical procedures in other fi sh species. In our experience, many fi sh that require advanced or lengthy surgical techniques often make it through the surgery only to decompensate or develop a metabolic crisis during recovery or shortly thereafter.
We have demonstrated that monitoring of metabolic status and vital signs is possible, but we have not explained how to monitor these trends over the long term or, more importantly, how to respond to signs of health problems. A movement away from immersion agents to injectable agents, which can be dosed more accurately based on individual weight, may help negate some of the variation that can occur with immersion agents, which are more affected by the water environmental status as well as the anatomy, physiology, and behavior of the fi sh species involved. The use of injectable agents does not, however, obviate the need for monitoring water quality. Alternatively, it may be worth considering immersion agents for induction (thus eliminating the need for handling awake fi sh), followed by administration of an injectable agent and postinduction removal of the fi sh to drug-free water.
